Abstract
Introduction: T cells, primarily CD4+ cells, play a significant role in xenograft rejection. While temporary T cell depletion alone prolongs islet xenograft survival in mice, repopulating T cells acquire a profile that fails to achieve xenograft tolerance. Human α1-antitrypsin (AAT) is an anti-inflammatory and immunomodulatory molecule that allows undeterred purified T cell responses, resulting in, unlike classic immunosuppression, expansion of regulatory T cells (Tregs). Alone, AAT promotes islet allograft survival and fails to extend islet xenograft survival. In combination with temporary T cell depletion, AAT significantly promotes rat-to-mouse islet xenograft survival. The mechanism behind this synergy is unknown.
| Original language | English |
|---|---|
| Pages (from-to) | O.2.5 |
| Journal | Xenotransplantation |
| Volume | 24 |
| Issue number | 5 |
| DOIs | |
| State | Published - Sep 2017 |
| Event | 14th Congress of the International Xenotransplantation Association - Baltimore, United States Duration: 21 Sep 2017 → 23 Sep 2017 |
Fingerprint
Dive into the research topics of 'Human Alpha1-Antitrypsin Therapy Synergizes with Temporary T Cell Depletion: Modified Repopulating T Cell Profile in Concordant and Discordant Xenoimmune Models'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver